ID   CRO-AP3
AC   CVCL_1810
SY   CRO-AP/3; CROAP3; AP3
DR   BTO; BTO:0002725
DR   CLO; CLO_0002618
DR   BioSample; SAMN03473339
DR   cancercelllines; CVCL_1810
DR   Cell_Model_Passport; SIDM00070
DR   Cosmic-CLP; 1297440
DR   DepMap; ACH-002393
DR   DSMZ; ACC-275
DR   DSMZCellDive; ACC-275
DR   GDSC; 1297440
DR   PharmacoDB; CROAP3_265_2019
DR   Wikidata; Q54814507
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=9734661;
RX   PubMed=9766492;
RX   PubMed=10784388;
RX   PubMed=30894373;
WW   http://www.cells-talk.com/index.php/page/copelibrary?key=CRO-AP%2f3
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Caucasian.
CC   Virology: Contains 10 to 30 copies of the human herpesvirus 8 (HHV-8/KSHV) genome per cell.
CC   Doubling time: ~50 hours (DSMZ=ACC-275).
CC   Transformant: NCBI_TaxID; 37296; Human herpesvirus 8 (HHV-8/KSHV).
CC   Omics: Deep exome analysis.
CC   Genome ancestry: African=2.63%; Native American=0%; East Asian, North=0.61%; East Asian, South=1.52%; South Asian=1.46%; European, North=42.74%; European, South=51.05% (PubMed=30894373).
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
ST   Source(s): DSMZ
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 11,12
ST   D16S539: 9,13
ST   D18S51: 12,16
ST   D19S433: 14,16
ST   D21S11: 30.2,32.2
ST   D2S1338: 21,24
ST   D3S1358: 14
ST   D5S818: 13
ST   D7S820: 10,12
ST   D8S1179: 15
ST   FGA: 21,26
ST   Penta D: 9,13
ST   Penta E: 12,14
ST   TH01: 8
ST   TPOX: 8
ST   vWA: 16,18
DI   NCIt; C6915; Primary effusion lymphoma
DI   ORDO; Orphanet_48686; Primary effusion lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   42Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 05-10-23; Version: 29
//
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RA   Drexler H.G.;
RT   "The leukemia-lymphoma cell line factsbook.";
RL   (In) ISBN 9780122219702; pp.1-733; Academic Press; London (2001).
//
RX   PubMed=9734661; DOI=10.1046/j.1365-2141.1998.00877.x;
RA   Carbone A., Cilia A.M., Gloghini A., Capello D., Todesco M.,
RA   Quattrone S., Volpe R., Gaidano G.;
RT   "Establishment and characterization of EBV-positive and EBV-negative
RT   primary effusion lymphoma cell lines harbouring human herpesvirus
RT   type-8.";
RL   Br. J. Haematol. 102:1081-1089(1998).
//
RX   PubMed=9766492; DOI=10.1038/sj.leu.2401160;
RA   Drexler H.G., Uphoff C.C., Gaidano G., Carbone A.;
RT   "Lymphoma cell lines: in vitro models for the study of HHV-8+ primary
RT   effusion lymphomas (body cavity-based lymphomas).";
RL   Leukemia 12:1507-1517(1998).
//
RX   PubMed=10784388; DOI=10.3109/10428190009148391;
RA   Carbone A., Cilia A.M., Gloghini A., Capello D., Perin T.,
RA   Bontempo D., Canzonieri V., Tirelli U., Volpe R., Gaidano G.;
RT   "Primary effusion lymphoma cell lines harbouring human herpesvirus
RT   type-8.";
RL   Leuk. Lymphoma 36:447-456(2000).
//
RX   PubMed=30894373; DOI=10.1158/0008-5472.CAN-18-2747;
RA   Dutil J., Chen Z.-H., Monteiro A.N.A., Teer J.K., Eschrich S.A.;
RT   "An interactive resource to probe genetic diversity and estimated
RT   ancestry in cancer cell lines.";
RL   Cancer Res. 79:1263-1273(2019).
//